Skip to content

"A Clinical study on the effect of diet, enema and oral medications in the management of Rheumatoid arthritis"

An open label single arm study to evaluate the efficacy of Panchkola yavagu, Vaishwanara churna basti followed by Erandadi gutika in Amavata w s r to Rheumatoid arthritis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035689
Enrollment
30
Registered
2021-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: PANCHKOLA YAVAGU VAISHWANARA CHURNA BASTI FALLOWED BY ERANDADI GUTIKA: PANCHKOLA YAVAGU WILL BE GIVEN FOR 3 TO 6 DAYS 12 GMS PER DAY VAISHWANARA CHURNA BASTI FOR 8 DAYS FALLOWED BY ERAN

Sponsors

SHRUTI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with lakshanas of Amavata Subjects presenting with signs and symptoms of Rheumatoid arthritis Subjects of either Gender Subjects between the age group 20 to 60years Subjects fit for Basti Karma

Exclusion criteria

Exclusion criteria: Subjects with other systemic disorders that interfere with the course of treatment Subjects presenting with complications of Rheumatoid Arthritis Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
To evaluate the combined effect of Panchkola yavagu Vaishwanara churna basti fallowed by Erandadi gutikaTimepoint: 27- 30 DAYS

Secondary

MeasureTime frame
NILTimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDR MANJUNATHA ADIGA

SRI KALABYRAVESHWARA SWAMY AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE

adiga.manjunatha@gmail.com9035715798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026